Skip to main content
Erschienen in: Annals of Surgical Oncology 13/2015

01.12.2015 | Thoracic Oncology

Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer

verfasst von: Satoshi Ida, MD, PhD, Masayuki Watanabe, MD, PhD, FACS, Naoya Yoshida, MD, PhD, FACS, Yoshifumi Baba, MD, PhD, Naoki Umezaki, MD, Kazuto Harada, MD, Ryuichi Karashima, MD, Yu Imamura, MD, PhD, Shiro Iwagami, MD, PhD, FACS, Hideo Baba, MD, PhD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Depletion of skeletal muscle mass (sarcopenia) indicates a poor prognosis for patients with several kinds of cancer, but it remains unclear whether esophageal squamous cell carcinoma (ESCC) is among these cancers. The aim of this study was to clarify the relationship between sarcopenia and postoperative outcome in patients with ESCC treated by esophagectomy.

Methods

Skeletal muscle mass was assessed in 138 patients who underwent esophagectomy from August 2009 to May 2014. A multifrequency bioelectrical impedance analysis (InBody 720; Biospace, Tokyo, Japan) was used to assess skeletal muscle mass just before surgery. Postoperative complications were graded according to the Clavien–Dindo classification, and univariate and multivariate analyses were performed for postoperative respiratory complications.

Results

Sarcopenia was determined in 61 patients (44.2 %). Preoperative pulmonary function was significantly lower and the rate of respiratory complications significantly higher in the sarcopenia group than in the non-sarcopenia group (p < 0.01). For other complications, the differences were not significant. Multivariate analysis showed that sarcopenia [odds ratio (OR) 5.82; p = 0.0001] and longer operation time (OR 3.09; p = 0.04) were risk factors for the occurrence of respiratory complications.

Conclusions

Sarcopenia may be a predictor of pulmonary complications after esophagectomy. Further analysis is needed to clarify whether nutritional intervention improves skeletal muscle mass and thus contributes to reducing postoperative respiratory complications in sarcopenic patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Gertler R, Stein HJ, Langer R, Nettelmann M, Schuster T, et al. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system. Ann Surg. 2011;253:689–98.CrossRefPubMed Gertler R, Stein HJ, Langer R, Nettelmann M, Schuster T, et al. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system. Ann Surg. 2011;253:689–98.CrossRefPubMed
3.
Zurück zum Zitat Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980;67:381–90.CrossRefPubMed Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980;67:381–90.CrossRefPubMed
4.
Zurück zum Zitat Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481–8.CrossRefPubMed Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481–8.CrossRefPubMed
5.
Zurück zum Zitat Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–47.CrossRefPubMed Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–47.CrossRefPubMed
6.
Zurück zum Zitat Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.CrossRefPubMed Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.CrossRefPubMed
7.
Zurück zum Zitat Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523–30.CrossRefPubMed Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523–30.CrossRefPubMed
8.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39:412–23.PubMedCentralCrossRefPubMed Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39:412–23.PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931–36.PubMedCentralCrossRefPubMed Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931–36.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Masuda T, Shirabe K, Ikegami T, Harimoto N, Yoshizumi T, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl. 2014;20:401–7.CrossRefPubMed Masuda T, Shirabe K, Ikegami T, Harimoto N, Yoshizumi T, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl. 2014;20:401–7.CrossRefPubMed
11.
Zurück zum Zitat Jaffrin MY, Morel H. Body fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys. 2008;30:1257–69.CrossRefPubMed Jaffrin MY, Morel H. Body fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys. 2008;30:1257–69.CrossRefPubMed
12.
Zurück zum Zitat Kim M, Kim H. Accuracy of segmental multi-frequency bioelectrical impedance analysis for assessing whole-body and appendicular fat mass and lean soft tissue mass in frail women aged 75 years and older. Eur J Clin Nutr. 2013;67:395–400.CrossRefPubMed Kim M, Kim H. Accuracy of segmental multi-frequency bioelectrical impedance analysis for assessing whole-body and appendicular fat mass and lean soft tissue mass in frail women aged 75 years and older. Eur J Clin Nutr. 2013;67:395–400.CrossRefPubMed
13.
Zurück zum Zitat Kaido T, Mori A, Ogura Y, Ogawa K, Hata K, et al. Pre- and perioperative factors affecting infection after living donor liver transplantation. Nutrition. 2012;28:1104–8.CrossRefPubMed Kaido T, Mori A, Ogura Y, Ogawa K, Hata K, et al. Pre- and perioperative factors affecting infection after living donor liver transplantation. Nutrition. 2012;28:1104–8.CrossRefPubMed
14.
Zurück zum Zitat Ida S, Watanabe M, Karashima R, Imamura Y, Ishimoto T, et al. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol. 2014;21:3675–9.CrossRefPubMed Ida S, Watanabe M, Karashima R, Imamura Y, Ishimoto T, et al. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol. 2014;21:3675–9.CrossRefPubMed
15.
Zurück zum Zitat Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.CrossRefPubMed Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.CrossRefPubMed
16.
Zurück zum Zitat Watanabe M, Nagai Y, Kinoshita K, Saito S, Kurashige J, et al. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer. Digestion. 2011;83:146–52.CrossRefPubMed Watanabe M, Nagai Y, Kinoshita K, Saito S, Kurashige J, et al. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer. Digestion. 2011;83:146–52.CrossRefPubMed
17.
Zurück zum Zitat Baba Y, Watanabe M, Shigaki H, Iwagami S, Ishimoto T, et al. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma. Surgery. 2013;153:234–41.CrossRefPubMed Baba Y, Watanabe M, Shigaki H, Iwagami S, Ishimoto T, et al. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma. Surgery. 2013;153:234–41.CrossRefPubMed
18.
Zurück zum Zitat Yoshida N, Baba Y, Watanabe M, Ida S, Ishimoto T, et al. An original scoring system for predicting postoperative morbidity after esophagectomy for esophageal cancer. Surg Today. 2015;45:346–54.CrossRefPubMed Yoshida N, Baba Y, Watanabe M, Ida S, Ishimoto T, et al. An original scoring system for predicting postoperative morbidity after esophagectomy for esophageal cancer. Surg Today. 2015;45:346–54.CrossRefPubMed
19.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.PubMedCentralCrossRefPubMed Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793–99.CrossRefPubMed Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793–99.CrossRefPubMed
21.
Zurück zum Zitat Koo HK, Park JH, Park HK, Jung H, Lee SS. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS One. 2014;9:e110448.PubMedCentralCrossRefPubMed Koo HK, Park JH, Park HK, Jung H, Lee SS. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS One. 2014;9:e110448.PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen city heart study. Am J Respir Crit Care Med. 2006;173:79–83.PubMed Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen city heart study. Am J Respir Crit Care Med. 2006;173:79–83.PubMed
23.
Zurück zum Zitat Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2014;14:58–74.CrossRef Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2014;14:58–74.CrossRef
24.
Zurück zum Zitat Bahat G, Tufan A, Ozkaya H, Tufan F, Akpinar TS, et al. Relation between hand grip strength, respiratory muscle strength and spirometric measures in male nursing home residents. Aging Male. 2014;17:136–40.CrossRefPubMed Bahat G, Tufan A, Ozkaya H, Tufan F, Akpinar TS, et al. Relation between hand grip strength, respiratory muscle strength and spirometric measures in male nursing home residents. Aging Male. 2014;17:136–40.CrossRefPubMed
25.
Zurück zum Zitat Chen Z, Wang Z, Lohman T, Heymsfield SB, Outwater E, et al. Dual-energy X-ray absorptiometry is a valid tool for assessing skeletal muscle mass in older women. J Nutr. 2007;137:2775–80.PubMed Chen Z, Wang Z, Lohman T, Heymsfield SB, Outwater E, et al. Dual-energy X-ray absorptiometry is a valid tool for assessing skeletal muscle mass in older women. J Nutr. 2007;137:2775–80.PubMed
26.
Zurück zum Zitat Jackson W, Alexander N, Schipper M, Fig L, Feng F, et al. Characterization of changes in total body composition for head and neck cancer patients undergoing chemoradiotherapy using dual-energy X-ray absorptiometry (DEXA). Head Neck. 2014;36:1356–62.CrossRefPubMed Jackson W, Alexander N, Schipper M, Fig L, Feng F, et al. Characterization of changes in total body composition for head and neck cancer patients undergoing chemoradiotherapy using dual-energy X-ray absorptiometry (DEXA). Head Neck. 2014;36:1356–62.CrossRefPubMed
27.
Zurück zum Zitat Han-Geurts IJ, Hop WC, Tran TC, Tilanus HW. Nutritional status as a risk factor in esophageal surgery. Dig Surg. 2006;23:159–63.CrossRefPubMed Han-Geurts IJ, Hop WC, Tran TC, Tilanus HW. Nutritional status as a risk factor in esophageal surgery. Dig Surg. 2006;23:159–63.CrossRefPubMed
28.
Zurück zum Zitat Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, et al. Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol. 2002;28:396–400.CrossRefPubMed Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, et al. Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol. 2002;28:396–400.CrossRefPubMed
29.
Zurück zum Zitat Kaido T, Uemoto S. Direct segmental multi-frequency bioelectrical impedance analysis is useful to evaluate sarcopenia. Am J Transplant. 2013;13:2506–7.CrossRefPubMed Kaido T, Uemoto S. Direct segmental multi-frequency bioelectrical impedance analysis is useful to evaluate sarcopenia. Am J Transplant. 2013;13:2506–7.CrossRefPubMed
30.
Zurück zum Zitat Grotenhuis BA, Wijnhoven BP, Grune F, van Bommel J, Tilanus HW, et al. Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol. 2010;101:270–8.PubMed Grotenhuis BA, Wijnhoven BP, Grune F, van Bommel J, Tilanus HW, et al. Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol. 2010;101:270–8.PubMed
31.
Zurück zum Zitat Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009;249:355–63.CrossRefPubMed Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009;249:355–63.CrossRefPubMed
Metadaten
Titel
Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer
verfasst von
Satoshi Ida, MD, PhD
Masayuki Watanabe, MD, PhD, FACS
Naoya Yoshida, MD, PhD, FACS
Yoshifumi Baba, MD, PhD
Naoki Umezaki, MD
Kazuto Harada, MD
Ryuichi Karashima, MD
Yu Imamura, MD, PhD
Shiro Iwagami, MD, PhD, FACS
Hideo Baba, MD, PhD, FACS
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 13/2015
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4559-3

Weitere Artikel der Ausgabe 13/2015

Annals of Surgical Oncology 13/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.